GeneID	MetaboliteID	CandidateAnnotation	SupportingSNPRecords	MinimumP	Scope	ThresholdP	Comparison	GenomeAnnotation
Glyma.17G212200	P00844		1	4.58218518728546e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P00877	Lupinic acid	1	7.12773058687051e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P03198	Lansoprazole	1	3.09409376652825e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P04365	Monascorubramine	1	5.27283395234842e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P06565	N-[(5-{2-[(6R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-D]pyrimidin-6-YL]ethyl}-2-thienyl)carbonyl]-L-glutamic acid	1	5.3394261160053e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P06599	Vitexin 2''-p-hydroxybenzoate	1	7.17196784750355e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P06758	alpha-Ethyl-alpha,beta-diphenyl-2-pyridineethanol	1	8.65729586988296e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P06798		1	7.27061717660631e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P07903	Coptisine	1	9.43894731225072e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P09497	2,5-Dimethylfuran	1	4.20559071031023e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P10446	Euchrenone a14	1	1.46235235929219e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P11037	2-(6,12,12-trichloro-dodecanoyloxy)-propanoic acid	1	9.85684118743488e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P12478	5,7-octadienoic acid	1	4.24804134282031e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P14251	N-4-[2(R)-Amino-3-mercaptopropyl]amino-2-naphthylbenzoyl-(L)-leucine, TFA	1	3.82059825337867e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P14549	Teucrolin D	1	8.73333019182422e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P14806	[3R-(3alpha,4beta,5alpha,5aalpha,6alpha,9beta,9aalpha,10R*)]-5-(Acetyloxy)-6-(benzoyloxy)octahydro-4,9-dihydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-yl ester 3-pyridinecarboxylic acid	1	8.97026434618741e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P15144	1-(4-Hydroxy-3,5-dimethoxyphenyl)-7-(4-hydroxy-3-methoxyphenyl)-3,5-heptanediol	1	2.63939791898051e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P19919	Parbendazole	1	3.36196494583189e-12	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P20559		1	7.47049927230398e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P20777	Huperzine T	1	9.60567897295676e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P22595	Mucronulatol-(4->5')-vestitol	1	7.24974508917647e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P22629	N-4-[2(R)-Amino-3-mercaptopropyl]amino-2-naphthylbenzoyl-(L)-leucine, TFA	1	1.48965910840137e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P24297		1	9.06814069862587e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P24867	Ethyl 5-[[[4-(3-methylsulfonylphenyl)phenyl]methyl-(2,4,6-trimethylphenyl)sulfonylamino]methyl]furan-2-carboxylate	1	8.68495142377918e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P26907	Mpomeovt	1	7.52276149578326e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P29935	Acantrifoside A	1	4.41951285123063e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P32569		1	6.49137898163675e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P33213		1	1.11763026297952e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P36683		1	7.29448038333294e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P37556		1	7.44047777169844e-13	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P37717	Lucuminamide	1	6.48938006693726e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P41025	CDP-DG(i-15:0/20:4(5Z,8Z,11Z,13E)+=O(15))	1	2.60198522570717e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P47101	Lofentanilum	1	4.07654879488426e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P47330	Tschimganical A	1	6.61713452125212e-11	overlap	1e-10	<	Wm82.a2.v1
Glyma.17G212200	P50556	Ethylbenzene	1	9.98266763973645e-11	overlap	1e-10	<	Wm82.a2.v1